Retevmo (selpercatinib)

News alerts, weekly reports and conference planners

Company:

Eli Lilly, Innovent Biologics, Pfizer

Drug class:

RET inhibitor

Related drugs:

RET fusion	Non Small Cell Lung Cancer	RET fusion	Non Small Cell Lung Cancer	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1
RET mutation	Thyroid Gland Medullary Carcinoma	RET mutation	Thyroid Gland Medullary Carcinoma	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1
RET fusion	Thyroid Gland Carcinoma	RET fusion	Thyroid Gland Carcinoma	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1
RET fusion	Solid Tumor	RET fusion	Solid Tumor	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1	selpercatinib Sensitive: A1 - Approval selpercatinib Sensitive : A1
RET fusion	Thyroid Gland Hurthle Cell Carcinoma	RET fusion	Thyroid Gland Hurthle Cell Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Thyroid Gland Follicular Carcinoma	RET fusion	Thyroid Gland Follicular Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Thyroid Gland Papillary Carcinoma	RET fusion	Thyroid Gland Papillary Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET rearrangement	Non Small Cell Lung Cancer	RET rearrangement	Non Small Cell Lung Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET mutation	Thyroid Gland Anaplastic Carcinoma	RET mutation	Thyroid Gland Anaplastic Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Neuroendocrine Tumor	RET fusion	Neuroendocrine Tumor	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Ovarian Cancer	RET fusion	Ovarian Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Salivary Gland Cancer	RET fusion	Salivary Gland Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Colon Cancer	RET fusion	Colon Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Hepatocellular Cancer	RET fusion	Hepatocellular Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Colorectal Cancer	RET fusion	Colorectal Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Pancreatic Adenocarcinoma	RET fusion	Pancreatic Adenocarcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Biliary Tract Cancer	RET fusion	Biliary Tract Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Peritoneal Cancer	RET fusion	Peritoneal Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Fallopian Tube Cancer	RET fusion	Fallopian Tube Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Cervical Cancer	RET fusion	Cervical Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Rectal Cancer	RET fusion	Rectal Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Esophageal Adenocarcinoma	RET fusion	Esophageal Adenocarcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Gastroesophageal Junction Adenocarcinoma	RET fusion	Gastroesophageal Junction Adenocarcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Esophageal Squamous Cell Carcinoma	RET fusion	Esophageal Squamous Cell Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Soft Tissue Sarcoma	RET fusion	Soft Tissue Sarcoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Gastric Cancer	RET fusion	Gastric Cancer	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Ampulla of Vater Carcinoma	RET fusion	Ampulla of Vater Carcinoma	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2	selpercatinib Sensitive: A2 - Guideline selpercatinib Sensitive : A2
RET fusion	Breast Cancer	RET fusion	Breast Cancer	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1
RET fusion	Sarcoma	RET fusion	Sarcoma	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1
RET fusion	Small Intestinal Carcinoma	RET fusion	Small Intestinal Carcinoma	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1
RET fusion	Pancreatic Cancer	RET fusion	Pancreatic Cancer	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1
RET fusion	Lung Adenocarcinoma	RET fusion	Lung Adenocarcinoma	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1	selpercatinib Sensitive: C1 - Off-label selpercatinib Sensitive : C1

Retevmo (selpercatinib)

Associations
(67)

Associations
(67)

Retevmo (selpercatinib)

Associations(67)

Associations(67)

Associations
(67)

Associations
(67)